首页 | 官方网站   微博 | 高级检索  
     

AHNAK2蛋白在食管鳞癌中的表达及其临床意义
引用本文:刘荟娟,商利,郝佳洁,蒋焱熠,石峰,王春丽,张钰,徐昕,蔡岩,黄大可,贾雪梅,王明荣. AHNAK2蛋白在食管鳞癌中的表达及其临床意义[J]. 癌变.畸变.突变, 2014, 0(1): 36-40. DOI: 10.3969/j.issn.1004-616x.2014.01.009
作者姓名:刘荟娟  商利  郝佳洁  蒋焱熠  石峰  王春丽  张钰  徐昕  蔡岩  黄大可  贾雪梅  王明荣
作者单位:(1.安徽医科大学组织胚胎学教研室,安徽 合肥230032;2.中国医学科学院北京协和医学院肿瘤医院分子肿瘤学国家重点实验室,北京 100021)
基金项目:分子肿瘤学国家重点实验室开放基金(SKL-KF-2013-14-19);863计划重大专项(2012AA02A503);国家自然科学基金(81021061)
摘    要:目的: 探讨AHNAK2蛋白在食管鳞状细胞癌中的表达情况及其对预后判断的意义。方法:应用组织微阵列免疫组织化学技术(TMA-IHC)研究129例食管鳞状细胞癌中AHNAK2蛋白的表达情况及其与临床病理指标之间的相关性。结果:AHNAK2蛋白在食管鳞癌组织中的表达率显著高于癌旁组织(P = 0.023),不表达、弱表达、中度表达和强表达的肿瘤比例分别为24.8% (32/129)、28.7%(37/129)、17.0%(22/129)和29.5%(38/129),且随着分化程度的升高,该蛋白的表达率也随之增高(P = 0.004)。Kaplan-Meier生存分析显示,AHNAK2蛋白表达阴性患者术后生存时间短于表达阳性的患者(P = 0.027)。通过多因素回归分析发现,AHNAK2蛋白是一个独立预后因素(P = 0.018,HR = 0.461,95% CI:0.243~0.877)。结论:AHNAK2蛋白在食管鳞癌中表达上调,且与分化程度相关,有可能作为食管鳞癌预后判断的分子标志物。

关 键 词:食管鳞状细胞癌  AHNAK2  免疫组化  组织微阵列  预后
收稿时间:2013-09-29

Expression and clinical relevance of AHNAK2 in esophageal squamous cell carcinoma
LIU Hui-juan,SHANG Li,HAO Jia-jie,JIANG Yan-yi,SHI Feng,WANG Chun-li,ZHANG Yu,XU Xin,CAI Yan,HUANG Da-ke,JIA Xue-mei,WANG Ming-rong. Expression and clinical relevance of AHNAK2 in esophageal squamous cell carcinoma[J]. Carcinogenesis,Teratogenesis and Mutagenesis, 2014, 0(1): 36-40. DOI: 10.3969/j.issn.1004-616x.2014.01.009
Authors:LIU Hui-juan  SHANG Li  HAO Jia-jie  JIANG Yan-yi  SHI Feng  WANG Chun-li  ZHANG Yu  XU Xin  CAI Yan  HUANG Da-ke  JIA Xue-mei  WANG Ming-rong
Affiliation:(1. Histology and Embryology of Anhui Medical University,Hefei 230032,Anhui;2. State Key Laboratory of Molecular Oncology,Cancer Institute & Hospital,Peking Union Medical College and Chinese Academy of Medical Sciences,Beijing 100021, China)
Abstract:OBJECTIVE:This study aimed to evaluate the expression and prognostic significance of AHNAK2 protein in esophageal squamous cell carcinoma (ESCC). METHODS:The alteration and clinical relevance of AHNAK2 protein levels were investigated in 129 ESCC cases by immunohistochemistry. RESULTS:The expression of AHNAK2 protein was up-regulated in some of ESCC tissues. Negative,weak,moderate and high expression of AHNAK2 were observed in 24.8% (32/129),28.7% (37/129),17.0% (22/129),and 29.5% (38/129) of tumors,respectively. Positive expression of AHNAK2 was significantly correlated with tumor differentiation (P=0.004). Kaplan-Meier survival curves showed that ESCC patients with negative expression of AHNAK2 had shorter overall survival time (P=0.027). Cox regression analysis indicated that AHNAK2 protein expression was an independent prognostic factor (P=0.018,HR=0.461,95%CI:0.243-0.877). CONCLUSION:AHNAK2 was overexpressed in ESCC tissues and correlated with tumor differentiation. AHNAK2 expression might contribute to the prognostic evaluation of patients with this disease.
Keywords:esophageal squamous cell carcinoma  AHNAK2  immunohistochemistry  tissue microarray  prognosis
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《癌变.畸变.突变》浏览原始摘要信息
点击此处可从《癌变.畸变.突变》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号